CEO Cristiana Pires receives 2022 RFS Award for publication in Cellular Reprogramming journal

Posted 7 August, 2023

Asgard’s Therapeutics CEO Cristiana Pires has been honored with the prestigious 2022 annual Rosalind Franklin Society (RFS), in partnership with Mary Ann Libert, Inc., publishers, Award in Science for her publication in Cellular Reprogramming journal, co-authored with Filipe Pereira, recognizing exceptional contributions of women and underrepresented minority scientists, physicians, and engineers.